Crystal meth addiction – medically-led detox and treatment

Crystal meth is the crystalline form of methamphetamine. It’s a Class A controlled substance in the UK, and is most commonly smoked, injected, or snorted. You may hear it referred to as Tina, ice, crank, or glass.

Methamphetamine was once used medically, but the illicit version is an entirely different substance. According to the UK’s focal point annual report, the prevalence of methamphetamine use in the general population remains very low – at around 0.03% – in England and Wales. But within specific communities, particularly among men who have sex with men in chemsex contexts, it can be far more prevalent.

Research published in the journal Pharmacological Research describes methamphetamine as a stimulant with short-term effects on mood, alertness, and energy – addiction develops because of how the drug acts on the brain’s reward system. Research in Drug and Alcohol Dependence notes that the crystalline form carries a higher risk of dependence than lower-purity variants, particularly when smoked or injected.

When you take crystal meth, the brain is flooded with dopamine, serotonin, and noradrenaline simultaneously in a way that overrides ordinary self-regulation.

What makes meth distinct from most other stimulants is the scale and duration of that effect; the high can last up to 12 hours. Over time, the brain adjusts by reducing natural dopamine production. 

Tolerance can also build rapidly, and over time higher doses are needed for the same effect.

Physical changes are usually what the people around someone notice first. They include:

• Significant weight loss and loss of appetite
• Dental problems, including tooth decay and gum damage
• Disrupted sleep, including long periods without sleep followed by extended crashes
• Skin changes, including sores caused by picking
• Elevated heart rate and blood pressure

Behavioural changes can be harder to read, particularly in the early stages. You might notice:

• Mood instability, including intense agitation or sudden crashes
• Paranoia, unusual suspicion, or fearfulness
• Withdrawal from people and activities that previously mattered
• Periods of intense focus or energy, followed by prolonged exhaustion
• Difficulty concentrating or remembering things after use
• Telling yourself you could stop if circumstances changed, but not testing it
• Feeling more like yourself when you’re using than when you’re not
• A sense that something is wrong, but not wanting to look at it too closely

Clinically, crystal meth addiction is referred to as a stimulant use disorder. This means that a person continues to use meth despite clear harm to their life. The line between use and dependence isn’t something people can easily recognise in themselves – especially not early on. 

Signs that dependence has developed include using more than you intended, or finding it difficult to stop even when the consequences are visible. 

It’s easy to tell yourself it’s recreational, or that you could stop when circumstances change. But many people find, when they look back, that they’d been minimising what was happening for longer than they realised. 

Chronic use of crystal meth is associated with depression, anxiety, paranoia, and, in some cases, stimulant-induced psychosis. The NHS describes severe psychosis as a serious mental state where you lose touch with reality and believe things that aren’t true.

When someone stops using, the crash that follows is driven by a brain that has stopped producing dopamine at normal levels. Early recovery can feel worse before it feels better. The depression that follows stopping is not permanent, but clinical support at this stage makes a real difference. 

You can read more about the link between meth use and depression.

According to the NHS, crystal meth increases heart rate and blood pressure, raising the risk of heart attack at higher doses. Crystal meth overdose can lead to stroke, as well as lung, kidney, and gastrointestinal damage.

For people who inject, there are additional risks, including exposure to HIV and hepatitis C through shared equipment. Long-term use is associated with memory loss and neurological damage.

The effects on daily life often become impossible to ignore, as crystal meth erodes relationships and someone’s sense of who they are.

The slow withdrawal from people and things that mattered is often what families notice first and it can be frightening. But meth carries a stigma that makes it hard to talk about, even with people you trust.

No. Pharmaceutical methamphetamine exists under the brand name Desoxyn. It is used only very rarely, primarily in the United States for obesity and Attention Deficit Hyperactivity Disorder (ADHD). It bears no practical resemblance to illicit crystal meth, which is manufactured illegally at far higher concentrations.

Cognitive Behavioural Therapy (CBT) is widely used and well-evidenced for stimulant dependence, helping people identify and change the thought patterns and behaviours that maintain use. Contingency management uses structured rewards to support abstinence. It has the strongest evidence base of any treatment for stimulant dependence, and it is significantly underused in the UK. Both approaches feature in Castle Health’s treatment model. 

Yes. Crystal meth rarely appears alone, particularly for people using in a chemsex context where it’s often combined with GHB, mephedrone or cocaine. Castle Health’s programme is designed for polysubstance use and cross-addiction. Treatment addresses the full picture, including any co-occurring mental health conditions.

Yes. Castle Health’s family support programme runs alongside treatment. For peer-to-peer support, organisations including Families Anonymous and Adfam offer community-based help for families affected by someone’s drug use. For families where crystal meth has been used in a chemsex context, London Friend’s Antidote service also provides family-facing resources.